AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 24th, 2008 • Icagen Inc • Pharmaceutical preparations
Contract Type FiledDecember 24th, 2008 Company IndustryThis AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Amendment”) is entered into as of December 24, 2008 by and between Icagen, Inc. (the “Company”), a Delaware corporation with offices located at 4222 Emperor Boulevard, Suite 350, Durham, North Carolina 27703, and Richard D. Katz (“Executive”), whose address is 209 Sierra Drive, Chapel Hill, North Carolina, 27514.
AMENDMENT NO. 2 TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 24th, 2008 • Icagen Inc • Pharmaceutical preparations
Contract Type FiledDecember 24th, 2008 Company IndustryThis AMENDMENT NO. 2 TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Amendment”) is entered into as of December 24, 2008 by and between Icagen, Inc. (the “Company”), a Delaware corporation with offices located at 4222 Emperor Boulevard, Suite 350, Durham, North Carolina 27703, and Seth V. Hetherington (“Executive”).
AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 24th, 2008 • Icagen Inc • Pharmaceutical preparations
Contract Type FiledDecember 24th, 2008 Company IndustryThis AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Amendment”) is entered into as of December 24, 2008 by and between Icagen, Inc. (the “Company”), a Delaware corporation with offices located at 4222 Emperor Boulevard, Suite 350, Durham, North Carolina 27703, and P. Kay Wagoner, Ph.D. (“Executive”), whose address is 1001 Monterey Valley, Chapel Hill, North Carolina, 27516.